Improves Visual Acuity
Improves Contrast Sensitivity
Reduces Central Drusen Volume
LumiThera is a medical device company at the forefront in the development of photobiomodulation (PBM) treatment protocols for patients with dry AMD.
Age-related macular degeneration (AMD) is the leading cause of blindness in adults over 65. There are two forms of AMD: dry and wet. Approximately 90% of patients with AMD have the dry form and 10% have the wet form.
CAUTION Investigational device. Limited by Federal (or United States) law to investigational use.
We use cookies to improve your experience on our website. By continuing to use this site, you agree to (1) our use of cookies and similar technologies, and (2) all other terms of our Privacy Statement available here for your review.